Aurora Cannabis Inc. (ACBFF) Celebrates Adult Consumer Legalization in Canada

On this historic day, Aurora Cannabis Inc. (“Aurora” or the “Company”)(ACB.TO) (ACBFF) ( Frankfurt : 21P; WKN: A1C4WM), is proud to celebrate consumer legalization by commending governments of all levels for their commitment to bringing an end to the prohibition of cannabis for adult consumer use, and acknowledging the decades of activism and effort that have led to this moment.

With retail sales beginning in provinces across the country today, Canada is the first G20 country to take this historic, transformative step. The country now stands as the world leader in cannabis public policy, innovation and acceptance.

“It’s a proud day to be Canadian,” said Aurora CEO Terry Booth . “For the last three years, the world has watched as we prepared for legalization as an industry and a country. The end of prohibition is a victory for advocates, for activists, for science, for personal freedom and for common sense. The Canadian Cannabis Community is strong, smart and resilient. Aurora respect and honor the will of advocates and activists who fought and continue to fight unjust laws that limited the righteous adult access to cannabis.

Aurora is one of Canada’s leading licensed producers and a developer of high-quality cannabis products to markets across the country and around the world. This thriving new Canadian industry has created jobs and prosperity across Canada and Canada is setting the global standard in crop production, product quality, cannabis science, and patient care.

Global Leaders

Canada has now become the second country in the world following Uruguay to fully legalize adult consumer cannabis. On the medical side at least 31 countries around the world have federally regulated medical cannabis.

“Today is a day the world will not soon forget,” said Neil Belot , Aurora’s Chief Global Business Development Officer. ” Canada has taken an evidence-based approach to legalization after nearly a century-long misstep, and as a result we have made our great country a healthier and safer place for our families, communities, and international visitors. We call on our cannabis advocates around the world to follow Canada’s lead. Aurora’s Science Team will continue to  support and advance evidence-based, sensible, public-health approaches to all forms of cannabis policy, particularly as it relates to the commercial, food-based, wellness, medical, research, and adult consumer use sectors.”

Medical cannabis comes first at Aurora

While legalization of cannabis for adult consumer use is an exciting milestone, as Canada’s leading licensed producer of medicinal cannabis, together with wholly-owned subsidiaries CanniMed and MedReleaf, Aurora reconfirms its commitment to its medical patients, including the Canadian veteran community.

“Cannabis as a medicine is a need, not an option,” said Aurora’s Chief Corporate Officer Cam Battley . “Our goal will always be to provide our patients with the greatest choice and flexibility in reliable, high-quality cannabis. We also commit to working with advocates, industry and governments across Canada to push for tax fairness for medical cannabis, something of critical importance to patients with chronic health conditions who find symptom relief in medical cannabis, but who often lack sufficient funds to afford the medication that helps them most.”

Aurora and MedReleaf Consumer Brands Available Across Canada

Aurora is proud to work with government and private retailers across Canada to supply a broad range of dried flower and higher margin products such as pre-rolls, oils, and capsules. Aurora’s integrated teams and its  strategic partners, have entered into supply arrangements with provinces and territories accounting for more than 98 per cent of the Canadian population. The Aurora and MedReleaf brands, including San Rafael ’71 and AltaVie, are expected to have a strong presence across the country, positioning the Company well for rapid growth.

“We are proud of the science and innovation that have gone into developing our adult-use brands and expect them to resonate well with consumers across Canada ,” said Darren Karasiuk , Executive Vice President, Global Adult Usage. “Both Aurora and MedReleaf have developed expertise and technology to consistently grow premium-grade cannabis for discerning adults and we are confident that adult consumers will soon see how we differentiate ourselves from the others.”